ClinicalTrials.gg
Not yet recruitingNCT05785312Updated Mar 27, 2023

Development of Online EMDR Therapy System and Its Comparative Testing With Face-to-Face EMDR Therapy for Treatment of Anxiety and Depressive Disorders in Pakistan

An interventional study of Online EMDR Therapy System and Face to Face Eye Movement Desensitization & Reprocessing Therapy in Generalized Anxiety Disorder, Major Depressive Disorder and Social Anxiety Disorder, sponsored by Khushal Khan Khattak Univeristy, Karak, Pakistan. Not yet recruiting at 1 site in Pakistan. Open to participants aged 18 Months to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-03-27.

Sponsored by Khushal Khan Khattak Univeristy, Karak, Pakistan · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jul 2025, 1 year 4 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Months to 50 Years
Sex
All
01

Study summary

This study aims at developing an online system for the remote delivery of EMDR therapy in Pakistan. Moreover, this study will compare the efficacy of online EMDR therapy with face-to-face EMDR therapy.

Read the detailed description

Depressive and Anxiety disorders have higher global prevalence. Moreover, they are leading causes of global burden of mental diseases (i.e., 24th leading cause of global Disability-adjusted Life Years). Such increase in the global prevalence of Depression and Anxiety disorders is due to the complexities of modern life. Nowadays various evidence-based psychotherapies, like e.g., EMDR therapy are available. Therapists have been using face-to-face modes for a long time, but with the expansion of Computer Technologies, online psychotherapies have been developed. The need for online psychotherapies was further increased due to Corona Virus-19 pandemic. Scientists have developed online modes of Cognitive Behavioral Therapy, Prolonged Exposure Therapy and Mindfulness Therapy, etc., but there are limited research studies on the online EMDR therapy, especially in the Asian countries. Therefore, questions arises a) Is it possible to treat Anxiety \& Depressive disorders through online EMDR therapy? b) What adaptations would be required to be made in the face-to-face protocols of EMDR therapy? c) Whether the online EMDR therapy will be: i) fit and safe for use; ii) usable; iii) operable \& practicable; and iv) efficient in delivering a timely treatment? The existing online programs of EMDR Therapy, e.g., VirtualEMDR have been built in the western-developed countries, hence may not be accessible to the local patients in Pakistan. Moreover, these programs might not be compatible with the requirements of patients in Pakistan. Keeping in view such facts, this study aims at developing an online system for the remote delivery of EMDR therapy in Pakistan. Moreover, this study will compare the efficacy of online EMDR therapy with face-to-face EMDR therapy. For this purpose, patients will be recruited through a consecutive sampling technique, with a sample size of n=30. Data on symptomology and other technical data will be collected through standard scales. Qualitative data were analyzed by qualitative techniques, while the quantitative data were analyzed by descriptive and multivariate statistics. This study will be unique in its nature since a) an online EMDR therapy will be developed for Pakistani patients, b) this online system will be scientifically validated, c) and its efficacy will be compared with face-to-face EMDR therapy. This study will provide a base for the future researchers to design and implement online psychotherapies in Pakistan. In this way, the mental healthcare system of Pakistan could be ultimately revolutionized through the online treatment facilities.

02

Conditions studied

  • Generalized Anxiety Disorder
  • Major Depressive Disorder
  • Social Anxiety Disorder
  • Somatic Symptom
  • Panic Attacks
  • Obsessive-Compulsive Disorder and Symptoms

Keywords

  • EMDR
  • Online EMDR
  • Depression
  • Anxiety
  • Pakistan
  • Pilot Study
03

In context

Generalized Anxiety Disorder

517 studies on the registry are indexed under Generalized Anxiety Disorder; 124 are open to participants now.

This study's planned enrollment of 30 is below the median of 83 across 439 interventional studies indexed under Generalized Anxiety Disorder.

Browse Generalized Anxiety Disorder studies →

Lead sponsor

Khushal Khan Khattak Univeristy, Karak, Pakistan is the lead sponsor of 4 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Months to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:

  1. Both male and female patients.
  2. Patients between the age of 18 to 50 years (since this study is neither on children nor on old patients).
  3. Patients who have basic knowledge \& skills of computer, mobile and internet (although the recruited patients will be given training for using the online EMDR).
  4. Patients do not suffer from severe neuropsychological and cognitive impairments.
  5. Patients have not received any pharmacological therapy in the last three months.
  6. Patients have not received any other psychotherapy like Cognitive Behavioral Therapy.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Face to Face Eye Movement Desensitization & Reprocessing Therapy

    The standard Face to Face Eye Movement Desensitization \& Reprocessing Therapy will be applied by a trained clinical psychologist through in person face to face sessions.

    Other: Face to Face Eye Movement Desensitization & Reprocessing Therapy

  • Active comparator
    Online Eye Movement Desensitization & Reprocessing Therapy

    The Online Eye Movement Desensitization \& Reprocessing Therapy will be applied by a trained clinical psychologist through computer system by connecting through internet. For this purpose the online EMDR therapy application software will be installed

    Device: Online EMDR Therapy System

Interventions

  • DeviceOnline EMDR Therapy System

    Online EMDR Therapy System will be delivered through online computer system that will be specifically designed for delivering EMDR therapy online

  • OtherFace to Face Eye Movement Desensitization & Reprocessing Therapy

    The Face to Face Eye Movement Desensitization \& Reprocessing Therapy will be delivered in person inside clinician's room by following standard EMDR therapy protocol

06

What researchers measure

Primary outcomes

  1. Assessing changes in symptom of Generalized Anxiety Disorder with time (i.e., treatment course)

    Generalized Anxiety Disorder by Generalized Anxiety Disorder Questionnaire-IV. Score of 5.7 or above will indicate that the patient is suffering from Generalized Anxiety Disorder.

    Time frame: A total of 40 patients will be selected. Symptoms will be screened for 06 months in such a way that symptoms will be assessed first during base line (T1), then during mid of treatment (T2), and finally at the end of treatment (T3)

  2. Assessing changes in symptom of Major Depressive Disorder with time (i.e., treatment course)

    Major Depressive Disorder by Beck Depression Inventory-II. Score of 30 or above will indicate that the patient is suffering from major depressive disorder

    Time frame: A total of 40 patients will be selected. Symptoms will be screened for 06 months in such a way that symptoms will be assessed first during base line (T1), then during mid of treatment (T2), and finally at the end of treatment (T3)

  3. Assessing changes in symptom of Social Anxiety Disorder with time (i.e., treatment course)

    Social Anxiety Disorder will be assed by Social Anxiety Scale. Score of 60 or above will indicate that the patient is suffering from Social Anxiety Disorder.

    Time frame: A total of 40 patients will be selected. Symptoms will be screened for 06 months in such a way that symptoms will be assessed first during base line (T1), then during mid of treatment (T2), and finally at the end of treatment (T3)

Secondary outcomes

  1. Assessing changes in Panic symptoms with time (i.e., treatment course)

    Panic Attacks by Panic Disorder Severity Scale. Score of 20 or above will indicate that the patient is suffering form panic symptoms.

    Time frame: A total of 40 patients will be selected. Symptoms will be screened for 06 months in such a way that symptoms will be assessed first during base line (T1), then during mid of treatment (T2), and finally at the end of treatment (T3)

  2. Assessing changes in Somatic symptoms

    Somatic Symptoms by the Somatic Symptom Scale-8. Score of 11 or above will indicate that the patient is suffering from somatic symptoms.

    Time frame: A total of 40 patients will be selected. Symptoms will be screened for 06 months in such a way that symptoms will be assessed first during base line (T1), then during mid of treatment (T2), and finally at the end of treatment (T3)

  3. Assessing changes in Obsessive symptoms with time (i.e., treatment course)

    Obsessive Compulsive Symptoms by Dimensional Obsessive-Compulsive Scale. Score of 15 or above on each dimension will indicate that the patient is having Obsessive Compulsive Symptoms.

    Time frame: A total of 40 patients will be selected. Symptoms will be screened for 06 months in such a way that symptoms will be assessed first during base line (T1), then during mid of treatment (T2), and finally at the end of treatment (T3)

07

Study locations

1 site
  • Kushal Khan University
    Lakki Marwat, Khyber Pakhtunkhwa 28420, Pakistan
08

References and documents

Individual participant data

Plan to share: No — will only be shared after placing valid request

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 27, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05785312
Lead sponsor
Khushal Khan Khattak Univeristy, Karak, Pakistan
Responsible party
Dr. Anwar Khan (Dr. Anwar Khan, Director and Principal Investigator, Office of Research, Innovation and Commercialization, Khushal Khan Khattak Univeristy, Karak, Pakistan) — Principal investigator
First posted
Mar 27, 2023
Start date
Jul 1, 2023 (estimated)
Primary completion
Jul 1, 2025 (estimated)
Completion
Aug 1, 2025 (estimated)
Last update
Mar 27, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion